Abstract Details

Title Interim Analysis of a Pilot Trial of Natalizumab in Inclusion Body Myositis

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) (-)

Poster/Presentation
Number 161

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Todd D. Levine, MD (Honor Health) PRESENTER	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
David S. Saperstein, MD (Center for Complex Neurology, EDS & POTS)	No disclosure on file

��ɫ����